BioStem Technologies, Inc. (BSEM)
1.50
+0.02
(+1.35%)
USD |
NASDAQ |
Oct 28, 13:36
BioStem Technologies Cash from Operations (Quarterly) : -5.538M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.538M |
| March 31, 2026 | -0.8255M |
| December 31, 2025 | 2.828M |
| September 30, 2025 | -2.383M |
| June 30, 2025 | 5.422M |
| March 31, 2025 | 4.074M |
| December 31, 2024 | 8.148M |
| September 30, 2024 | 9.416M |
| June 30, 2024 | 6.343M |
| March 31, 2024 | 0.5542M |
| December 31, 2023 | -1.423M |
| September 30, 2023 | -0.451M |
| June 30, 2023 | -0.9607M |
| March 31, 2023 | -0.6645M |
| December 31, 2022 | -0.4427M |
| September 30, 2022 | -0.317M |
| June 30, 2022 | 0.4662M |
| March 31, 2022 | 0.5971M |
| December 31, 2021 | 0.0484M |
| September 30, 2021 | -0.0848M |
| June 30, 2021 | 1.072M |
| March 31, 2021 | -1.145M |
| December 31, 2020 | -0.4622M |
| September 30, 2020 | -0.1756M |
| June 30, 2020 | -0.4019M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0269M |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | -0.48M |
| December 31, 2018 | -1.119M |
| September 30, 2018 | -1.428M |
| June 30, 2018 | -0.5528M |
| March 31, 2018 | -0.5606M |
| December 31, 2017 | -0.3737M |
| September 30, 2017 | -0.3728M |
| June 30, 2017 | -0.4098M |
| March 31, 2017 | -0.4902M |
| December 31, 2016 | -1.47M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.0134M |
| March 31, 2016 | -0.2376M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | -0.0494M |
| March 31, 2014 | -0.0675M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -3.855M |
| CorMedix, Inc. | 86.06M |
| Eloxx Pharmaceuticals, Inc. | -4.789M |
| Breakthrough Chemistry, Inc. | -0.0073M |
| Cardiac Biotech Solutions, Inc. | -0.1918M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0561M |
| Cash from Financing (Quarterly) | -1.146M |
| Free Cash Flow | -8.832M |
| Free Cash Flow Per Share (Quarterly) | -0.3229 |
| Free Cash Flow to Equity (Quarterly) | -3.539M |
| Free Cash Flow to Firm (Quarterly) | -5.595M |
| Free Cash Flow Yield | -31.73% |